Skip to content

Clinical trials

Prostatic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Country / region: Taiwan Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20073
20084
20091
20103
20116
20121
20135
20147
20153
20164
20177
20185
201910
20208
20216
20227
20234
20247
202513
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting22
Recruiting21
Unknown status15
Terminated7
Withdrawn2
Not yet recruiting1
Approved for marketing1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital14
AstraZeneca9
Chang Gung Memorial Hospital9
Janssen Research & Development, LLC6
Novartis Pharmaceuticals6
Pfizer6
Merck Sharp & Dohme LLC5
Sanofi5
Amgen4
Bayer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms110
Breast Neoplasms8
Neoplasms8
Neoplasm Metastasis7
Melanoma6
Carcinoma, Non-Small-Cell Lung5
Ovarian Neoplasms4
Carcinoma, Hepatocellular3
Pancreatic Neoplasms3
Recurrence3

Trials

Showing 51 to 75 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.